Evidence map›Paper›PMID 38634747›Full record

ArticleJournal of the American Geriatrics Society2024

The impact of multimorbidity and functional limitation on quality of life in patients with heart failure: A multi-site study.

Sheila M Manemann, Erinn M Hade, Irina V Haller, Benjamin D Horne, Catherine P Benziger, Brent C Lampert, Kismet D Rasmusson, Veronique L Roger, Susan A Weston, Jill M Killian and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of the American Geriatrics Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Multidimensional functional limitations in American cancer survivors: Characteristics and their effects on survival and healthcare utilization.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sheila M ManemannDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Erinn M HadeDepartment of Population Health, NYU Grossman School of Medicine, New York, New York, USA.
Irina V HallerEssentia Institute of Rural Health, Essentia Health, Duluth, Minnesota, USA.
Benjamin D HorneIntermountain Medical Center Heart Institute, Salt Lake City, Utah, USA.
Catherine P BenzigerHeart and Vascular Center, Essentia Health, Duluth, Minnesota, USA.ORCID 0000-0002-8992-6197
Brent C LampertDivision of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Kismet D RasmussonIntermountain Medical Center Heart Institute, Salt Lake City, Utah, USA.
Veronique L RogerDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Susan A WestonDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Jill M KillianDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Alanna M ChamberlainDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.

Funding

'Heart Failure in the Community: Multimorbidity and Outcomes'R01HL120859 · NHLBI · MAYO CLINIC ROCHESTER · PI ROGER, VERONIQUE LEE · 2014 to 2017
$3.2M
NHLBI NIH HHS R01 HL120859Patient Centered Outcomes Research Institute (PCORI) CDRN-1501-26638
6 · The paper itself

Abstract

backgroundMultimorbidity and functional limitation are associated with poor outcomes in heart failure (HF). However, the individual and combined effect of these on health-related quality of life in patients with HF is not well understood.

methodsPatients aged ≥30 years with two or more HF diagnostic codes and one or more HF-related prescription drugs from four U.S. institutions were mailed a survey to measure patient-centric factors including functional status (activities of daily living [ADLs]) and health-related quality of life (PROMIS-29 Health Profile). Patients with HF from January 1, 2013 to February 1, 2018 were included. Multimorbidity was defined as ≥2 non-cardiovascular comorbidities; functional limitation as any limitation in at least one of eight ADLs. Patients were categorized into four groups by multimorbidity (Yes/No) and functional limitation (Yes/No). We dichotomized the PROMIS-29 sub-scale scores at the median and calculated odd ratios for the four multimorbidity/functional limitation groups.

resultsA total of 3330 patients with HF returned the survey (response rate 31%); 3020 completed the questions of interest and were retained. Among these patients (45% female; mean age 73 [standard deviation: 12] years), 29% had neither multimorbidity nor functional limitation, 24% had multimorbidity only, 22% had functional limitation only, and 25% had both. After adjustment, having functional limitation only was associated with higher anxiety (odds ratio [OR]: 3.44, 95% confidence interval [CI]: 2.66-4.45), depression (OR: 3.11, 95% CI: 2.39-4.06), and fatigue (OR: 4.19, 95% CI: 3.25-5.40); worse sleep (OR: 2.14, 95% CI: 1.69-2.72) and pain (OR: 6.73, 95% CI: 5.15-8.78); and greater difficulty with social activities (OR: 9.40, 95% CI: 7.19-12.28) compared with having neither. Results were similar for having both multimorbidity and functional limitation.

conclusionPatients with only functional limitation have similar poor health-related quality of life scores as those with both multimorbidity and functional limitation, underscoring the important role that physical functioning plays in the well-being of patients with HF.

Indexed as

Activities of Daily LivingHeart FailureMultimorbidityQuality of LifeAgedAged, 80 and overFemaleFunctional StatusHumansMaleMiddle AgedSurveys and QuestionnairesUnited Statesfunctional limitationheart failuremultimorbidityquality of life

Identifiers

PMID38634747
PMCPMC11187645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.